N-Acetyl Selank is an enhanced version of Selank, a synthetic heptapeptide derived from the naturally occurring immunomodulatory peptide tuftsin. The N-acetylation modification provides improved stability and potentially enhanced bioavailability compared to standard Selank. The peptide exhibits both anxiolytic and nootropic properties, working through multiple mechanisms including modulation of GABA-A receptor expression, influence on serotonin and dopamine metabolism, and effects on brain-derived neurotrophic factor (BDNF). N-Acetyl Selank has been studied for its potential to reduce anxiety without sedation while simultaneously improving cognitive function, attention, and memory.
| Research Status | Research chemical |
|---|---|
| Half-Life | Minutes (rapid absorption) |
| Administration | Intranasal |
| Typical Dosage | 200-400 mcg |
| Molecular Weight | 793.9 Da (approximately) |
| Molecular Formula | C35H57N11O10 (acetylated form) |
Same as Selank with acetyl modification for improved stability and absorption.
All information is presented for Research Use Only (RUO). Not medical advice.